Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  As on 30 September 2025, Utmost Group PLC holds 3,385,235 units of TriSalus Life Sciences's common shares, representing 6.79% of the outstanding shares. On 08 July 2025, 21,193 units were acquired. On 23 July 2025, 588,000 units of preferred shares held by Utmost Group PLC were converted into 1,940,400 units of common shares. On 23 September 2025, Utmost Group PLC received 31,360 units of common shares paid in kind as insurance premium.


SCHEDULE 13G



 
Utmost Group PLC
 
Signature:/s/ Ian Maidens
Name/Title:Ian Maidens - Group CFO
Date:10/27/2025